Skip to content
Screener

AnaptysBio, Inc. ANAB Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Biogen logo
BiogenBIIB
$245.7M-26.5%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.29M-10.6%
Absci Corporation logo
Absci CorporationABSI
$2.44M-29.4%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$7.71M-33.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$983.41K+36.8%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$915K-39.4%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.64B+194%
Enterprise value$1.39B+163%
P/S7.1×+2.5×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219515
Line itemMarch 31, 2026(unaudited)December 31, 2025
Prepaid expenses and other current assets3,9074,762
Total current assets316,109350,250
Property and equipment, net1,2801,370
Operating lease right-of-use assets12,03912,519
Other long-term assets256256
Total assets$329,684$364,395
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:

Item 1. Consolidated Financial Statements

FAQ

What is AnaptysBio, Inc.'s operating lease ROU assets?
AnaptysBio, Inc. (ANAB) reported operating lease ROU assets of $12.04M in Q1 2026.
How has AnaptysBio, Inc.'s operating lease ROU assets changed year-over-year?
AnaptysBio, Inc.'s operating lease ROU assets decreased by 13.5% year-over-year, from $13.92M to $12.04M.
What is the long-term trend for AnaptysBio, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s operating lease ROU assets has grown at a 105.2% compound annual growth rate (CAGR), from $344K to $12.52M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about AnaptysBio, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude